Factors predict compliance with payer-led oncology clinical pathways
Source: Healio, November 2022
A study presented at this year’s ASCO Quality Care Symposium examined predictors of compliance with payer-led oncology clinical pathways.
The study included patients with one of several malignancies — including melanoma, breast cancer, lung cancer or colorectal cancer — treated in the first-line setting for metastatic disease.
“These findings would be of interest to policymakers focused on value-based cancer care,” Samyukta Mullangi, MD, MBA, third-year fellow in medical oncology at Memorial Sloan Kettering Cancer Center, and colleagues concluded.